{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:08:37Z","timestamp":1787018917588,"version":"build-2736575974"},"reference-count":78,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Vaccine therapeutics and the practice of immunization provision are ever-changing. As pharmacy-based immunization services continue to flourish in the United States, more and more patients are requesting both routine and travel vaccines in community pharmacies. However, vaccine recommendations from the Centers for Disease Control and Prevention\/Advisory Committee on Immunization Practices (CDC\/ACIP) can sometimes differ from product-specific US Food and Drug Administration (FDA)-indicated uses. In addition, changes in vaccine schedules, product availability, and disease outbreaks can present immunizing pharmacists with scenarios requiring a high level of clinical judgment. Thus, it is of paramount importance that all immunizing pharmacists maintain competency in the most recent evidence in vaccine therapeutics, as well as practice standards for vaccine provision and administration. This review provides an update of the most recent literature surrounding emerging topics in adolescent and adult immunizations\u2014highlighting influential studies and recent developments in the prevention of herpes zoster, human papillomavirus (HPV), measles, mumps, rubella (MMR), meningococcal disease, tetanus, diphtheria, and pertussis. Key concepts discussed include the emergence of the new recombinant zoster vaccine (RZV), meningococcal vaccine product selection, MMR revaccination during disease outbreaks, tetanus vaccine product selection, and duration of pertussis immunity with vaccination.<\/jats:p>","DOI":"10.1177\/0897190018802937","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:50:05Z","timestamp":1540335005000},"page":"192-205","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Emerging Topics in Vaccine Therapeutics for Adolescents and Adults: An Update for Immunizing Pharmacists"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-4670","authenticated-orcid":false,"given":"Joseph P.","family":"Fava","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA"},{"name":"Pharmacy Operations, Meijer, Inc, Grand Rapids, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Dudzinski","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Meijer, Inc, Grand Rapids, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Baker","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Meijer, Inc, Grand Rapids, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Volino","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"bibr1-0897190018802937","volume-title":"The Role of Community Pharmacies\/Pharmacists in Vaccine Delivery in the United States","author":"Rothholz M","year":"2013"},{"key":"bibr2-0897190018802937","doi-asserted-by":"crossref","unstructured":"Weaver KK. Pharmacist-administered immunizations: what does your state allow? 2015. http:\/\/www.pharmacist.com\/pharmacist-administered-immunizations-what-does-your-state-allow. Accessed December 11, 2017.","DOI":"10.1016\/S1042-0991(15)30130-4"},{"key":"bibr3-0897190018802937","unstructured":"Rothholz M. CDC releases Dear Pharmacist letter for seasonal influenza vaccination efforts. 2016. https:\/\/www.pharmacist.com\/cdc-releases-dear-pharmacist-letter-seasonal-influenza-vaccination-efforts. Accessed December 11, 2017."},{"key":"bibr4-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Shingles (Herpes Zoster). Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/shingles\/index.html. Accessed December 14, 2017. Reviewed October 17, 2017. Updated January 30, 2018."},{"key":"bibr5-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"bibr6-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir970"},{"key":"bibr7-0897190018802937","unstructured":"Gruber M. Biologics License Application (BLA) Approval. Silver Spring, MD: US Food & Drug Administration. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM581750.pdf. Accessed December 14, 2017."},{"key":"bibr8-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"bibr9-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"bibr10-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.073"},{"key":"bibr11-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix482"},{"key":"bibr12-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1265715"},{"key":"bibr13-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices: October 2017 Meeting Recommendations. Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/vaccines\/acip\/index.html. Accessed December 14, 2017. Reviewed April 15, 2016. Updated July 20, 2018."},{"key":"bibr14-0897190018802937","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"bibr15-0897190018802937","volume-title":"[Package insert]","author":"Shingrix (Zoster Vaccine Recombinant, Adjuvanted)","year":"2017"},{"key":"bibr16-0897190018802937","unstructured":"Immunization Action Coalition. Medical Management of Vaccine Reactions in Adult Patients. Saint Paul, MN: Immunization Action Coalition. http:\/\/www.immunize.org\/catg.d\/p3082.pdf. Accessed December 14, 2017. Reviewed March 13, 2017. Updated June 28, 2017."},{"key":"bibr17-0897190018802937","volume-title":"(Human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) [package insert]","author":"Cervarix","year":"2015"},{"key":"bibr18-0897190018802937","volume-title":"(Human papillomavirus quadrivalent [types 6, 11, 16, 18] vaccine, recombinant)","author":"Gardasil(R)","year":"2015"},{"key":"bibr19-0897190018802937","unstructured":"Gardasil(R) 9 [package insert]. Whitehouse Station, NJ: Merck & Co. 2017. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/g\/gardasil_9\/gardasil_9_pi.pdf. Accessed January 20, 2017."},{"key":"bibr20-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Clinician FAQ: CDC Recommendations for HPV Vaccine 2-Dose Schedules. Atlanta, GA: Centers for Disease Control and Prevention. 2016. https:\/\/www.cdc.gov\/hpv\/downloads\/hcvg15-ptt-hpv-2dose.pdf. Accessed December 18, 2017."},{"key":"bibr21-0897190018802937","volume-title":"Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger, UNITED STATES, 2018","author":"Centers for Disease Control and Prevention"},{"key":"bibr22-0897190018802937","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6549a5"},{"key":"bibr23-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.17615"},{"key":"bibr24-0897190018802937","unstructured":"Meningococcal Disease. Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/meningococcal\/about\/index.html. Accessed December 21, 2017. Updated March 28, 2017."},{"key":"bibr25-0897190018802937","volume-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","author":"Centers for Disease Control and Prevention","year":"2015","edition":"13"},{"key":"bibr26-0897190018802937","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22302"},{"key":"bibr27-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1203238"},{"key":"bibr28-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1177\/2051013616681365"},{"key":"bibr29-0897190018802937","unstructured":"Menhibrix Discontinuation Notice\u2014GSKDirect. 2016 https:\/\/www.gskdirect.com\/medias\/Menhibrix-Discontinuation-Notice.pdf?context=bWFzdGVyfHJvb3R8NTIyNzQxfGFwcGxpY2F0aW9uL3BkZnxoZTMvaDg1Lzg4NTg3MTMwNjM0NTQucGRmfGYxMjAyMDFmMmU2YjAwYzYyZmUxNWQyNTdjYmUzNjFjMTQ2MDUyODIyMjg4YWIzMTIzNjJhZTZjMWRlNjBlMzg. Accessed December 21, 2017."},{"key":"bibr30-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Clinical Update: Menomune (Meningococcal Polysaccharide Vaccine) Discontinuation. Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/wwwnc.cdc.gov\/travel\/news-announcements\/menomune-discontinuation. Accessed December 21, 2017. Updated March 24, 2017."},{"key":"bibr31-0897190018802937","volume-title":"(Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined) [Prescribing Information]","author":"Menomune","year":"2016"},{"issue":"2","key":"bibr32-0897190018802937","first-page":"1","volume":"62","author":"Cohn AC","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"key":"bibr33-0897190018802937","volume-title":"(Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) [prescribing information]","author":"Menactra(R)","year":"2016"},{"key":"bibr34-0897190018802937","volume-title":"(Meningococcal [Groups A, C, Y, and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) [prescribing information]","author":"Menveo(R)","year":"2017"},{"key":"bibr35-0897190018802937","doi-asserted-by":"publisher","DOI":"10.2165\/11204790-000000000-00000"},{"key":"bibr36-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Meningococcal Vaccination for Preteens and Teens: Information for Parents. Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/public\/adolescent-vaccine.html. Accessed 6 February 2018. Updated 19 May 2017."},{"key":"bibr37-0897190018802937","unstructured":"TRUMENBA(R). (Meningococcal Group B Vaccine) [Prescribing Information]. Philadelphia, PA: Wyeth Pharmaceuticals; 2017. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=1796. Accessed December 21, 2017."},{"key":"bibr38-0897190018802937","volume-title":"(Meningococcal Group B Vaccine) [Prescribing Information]","author":"BEXSERO(R)","year":"2017"},{"key":"bibr39-0897190018802937","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3439"},{"key":"bibr40-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614474"},{"key":"bibr41-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv039"},{"key":"bibr42-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30048-3"},{"key":"bibr43-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix154"},{"key":"bibr44-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514866"},{"key":"bibr45-0897190018802937","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"bibr46-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0869-7"},{"key":"bibr47-0897190018802937","unstructured":"M-M-R(R) II [package insert]. Whitehouse Station, NJ: Merck & Co; 2015. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM123789.pdf. Accessed December 11, 2017."},{"key":"bibr48-0897190018802937","unstructured":"Proquad(R) [package insert]. Whitehouse Station, NJ: Merck & Co; 2017. Accessed December 12, 2017."},{"key":"bibr49-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Measles, Mumps, and Rubella (MMR) Vaccination: What Everyone Should Know. Atlanta, GA: Centers for Disease Control and Prevention. 2016. https:\/\/www.cdc.gov\/vaccines\/vpd\/mmr\/public\/index.html. Accessed December 11, 2017. Updated November 22, 2016."},{"key":"bibr50-0897190018802937","unstructured":"Centers for Disease Control and Prevention. About the Vaccine. Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/vaccines\/vpd\/mmr\/hcp\/about.html. Updated February 2, 2018. Accessed December 12, 2017."},{"key":"bibr51-0897190018802937","volume-title":"Health, United States, 2016: With Chartbook on Long-term Trends in Health","author":"National Center for Health Statistics","year":"2017"},{"key":"bibr52-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Mumps Cases and Outbreaks. Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/mumps\/outbreaks.html. Updated February 9, 2018. Accessed February 15, 2018."},{"key":"bibr53-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703309"},{"key":"bibr54-0897190018802937","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6529a2"},{"issue":"04","key":"bibr55-0897190018802937","first-page":"1","volume":"62","author":"McLean HQ","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"bibr56-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1086\/588197"},{"key":"bibr57-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1086\/596207"},{"key":"bibr58-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu094"},{"key":"bibr59-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318279f593"},{"key":"bibr60-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0177"},{"key":"bibr61-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Agenda: Meeting of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/agenda-archive\/agenda-2017-10.pdf. Accessed October 19, 2017."},{"key":"bibr62-0897190018802937","unstructured":"ACIP Recommends Third MMR Vaccine During Mumps Outbreaks. SLACK Inc. (Healio.com). 2017. https:\/\/www.healio.com\/pediatrics\/vaccine-preventable-diseases\/news\/online\/%7B2fc4ccbd-d727-4f23-8d30-7dcce7b3a9ee%7D\/acip-recommends-third-mmr-vaccine-during-mumps-outbreaks. Accessed December 12, 2017."},{"key":"bibr63-0897190018802937","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6701a7"},{"key":"bibr64-0897190018802937","unstructured":"Boostrix(R) [package insert]. Rixensart, Belgium: GlaxoSmithKline; 2016. Accessed December 1, 2017."},{"key":"bibr65-0897190018802937","unstructured":"Adacel(R). [package insert]. Toronto, Ontario, Canada: Sanofi Pasteur. 2017. Accessed December 1, 2017."},{"issue":"25","key":"bibr66-0897190018802937","first-page":"468","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"Morb Mortal Wkly Rep"},{"key":"bibr67-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00083-15"},{"key":"bibr68-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv071"},{"key":"bibr69-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1729"},{"key":"bibr70-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00438-14"},{"key":"bibr71-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.07.068"},{"key":"bibr72-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.035"},{"key":"bibr73-0897190018802937","unstructured":"Centers for Disease Control and Prevention. Pertussis Cases by Year (1922-2015). Atlanta, GA: Centers for Disease Control and Prevention; https:\/\/www.cdc.gov\/pertussis\/surv-reporting\/cases-by-year.html. Accessed December 11, 2017. Reviewed August 7, 2017. Updated February 7, 2018."},{"key":"bibr74-0897190018802937","unstructured":"Kroger AT, Objio TS, Robinson CL, et al. Ask the Experts: Diseases & Vaccines\u2014Diphtheria, Tetanus, Pertussis. Saint Paul, MN: Immunization Action Coalition. http:\/\/www.immunize.org\/askexperts\/experts_per.asp. Accessed September 7, 2018. Reviewed September 7, 2018. Updated September 10, 2018."},{"key":"bibr75-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000202082.56403.c4"},{"key":"bibr76-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q651"},{"issue":"11","key":"bibr77-0897190018802937","first-page":"300","volume":"64","author":"Petrosky E","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"bibr78-0897190018802937","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.059"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190018802937","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190018802937","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190018802937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:35:12Z","timestamp":1777509312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190018802937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1177\/0897190018802937"],"URL":"https:\/\/doi.org\/10.1177\/0897190018802937","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]}}}